Chimerix

$8.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.43 (-4.64%) Today

-$0.21 (-2.46%) As of 12:41 PM UTC after-hours

Why Robinhood?

You can buy or sell Chimerix and other stocks, options, and ETFs commission-free!

About CMRX

Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC. The listed name for CMRX is Chimerix, Inc. Common Stock.

CEO

Michael A. Sherman

Employees

Headquarters

Durham, North Carolina

Founded

2000

Market Cap

713.36M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.65M

High Today

$9.23

Low Today

$8.52

Open Price

$8.83

Volume

1.22M

52 Week High

$10.72

52 Week Low

$1.19

Collections

CMRX Earnings

-$0.37

-$0.25

-$0.12

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 23, Pre-Market